scispace - formally typeset
Journal ArticleDOI

Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease

Reads0
Chats0
TLDR
Supplements combining folic acid and vitamins B6 and B12 did not reduce the risk of major cardiovascular events in patients with vascular disease.
Abstract
risk, 0.95; 95 percent confidence interval, 0.84 to 1.07; P = 0.41). As compared with placebo, active treatment did not significantly decrease the risk of death from cardiovascular causes (relative risk, 0.96; 95 percent confidence interval, 0.81 to 1.13), myocardial infarction (relative risk, 0.98; 95 percent confidence interval, 0.85 to 1.14), or any of the secondary outcomes. Fewer patients assigned to active treatment than to placebo had a stroke (relative risk, 0.75; 95 percent confidence interval, 0.59 to 0.97). More patients in the active-treatment group were hospitalized for unstable angina (relative risk, 1.24; 95 percent confidence interval, 1.04 to 1.49). Conclusions Supplements combining folic acid and vitamins B 6 and B 12 did not reduce the risk of major cardiovascular events in patients with vascular disease. (ClinicalTrials.gov number, NCT00106886; Current Controlled Trials number, ISRCTN14017017.)

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Determining the Relationship Between Homocysteinemia and Biomarkers of Inflammation, Oxidative Stress and Functional Kidney Status in Patients with Diabetic Nephropathy

TL;DR: It can be concluded that HHcy is significantly present in patients with diabetic nephropathy, especially if there is greater reduction of renal function, and it is useful to regularly monitor the levels of homocysteine, as well as inflammatory and markers of oxidative stress.
Journal ArticleDOI

Oxidative stress decreases extracellular homocysteine concentration in human hepatoma (HepG2) cell cultures.

TL;DR: The presence of hydrogen peroxide probably increases the activity of the trans-sulfuration pathway in hepatoma cell cultures, which increases the intracellular use of homocysteine and lowers its extracellular release, which might tend to lower total plasma homocy steine concentration in oxidative stress.
Book ChapterDOI

Algae and cardiovascular health

TL;DR: The chapter reviews controlled studies and publications regarding the effect of consuming seaweed and functional meat-containing algae on cholesterol and lipoprotein levels and thrombosis, and antioxidant availability and profile, and the possible interaction between algal compounds and some hypolipemic and hypotensive drugs.
Journal ArticleDOI

Plant-based dietary patterns in the control of obesity and cardiovascular risk

TL;DR: Well-planned plant-based diets are nutritionally adequate, well-accepted, and sustainable for the long term and represent an effective strategy in the control of obesity and cardiovascular disease risk.
Journal ArticleDOI

Effects of Vitamin B12 and Folic Acid on Hyperhomocysteinemia in Patients with Acute Myocardial Infarction

TL;DR: Vitamin B12 and folate deficiency in association with hyperhomocysteinemia in patients with acute myocardial infarction may be considered as a risk factor for CAD development.
References
More filters
Journal ArticleDOI

Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women

TL;DR: Treatment with oral conjugated equine estrogen plus medroxyprogesterone acetate did not reduce the overall rate of CHD events in postmenopausal women with established coronary disease and the treatment did increase the rate of thromboembolic events and gallbladder disease.
Journal ArticleDOI

Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

TL;DR: In this paper, the authors defined the definition of MI and established the following criteria for acute, evolving or recent MI: 1) Typical rise and gradual fall (troponin) or more rapid rise and fall (CK-MB) of biochemical markers of myocardial necrosis with at least one of the following: a) ischemic symptoms; b) development of pathologic Qwaves on the ECG; c) ECG changes indicative of ischemia (ST segment elevation or depression); or d) coronary artery intervention (e.g., coronary ang
Journal ArticleDOI

A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes

TL;DR: Higher folic acid intake by reducing tHcy levels promises to prevent arteriosclerotic vascular disease and under different assumptions, 13,500 to 50,000 CAD deaths annually could be avoided.
Journal ArticleDOI

Homocysteine and atherothrombosis

TL;DR: In 1969, McCully reported autopsy evidence of extensive arterial thrombosis and atherosclerosis in two children with elevated plasma homocyst(e)ine concentrations and homocysteine thiolactone, and it has recently become clear that hyperhomocyst (e)inemia is an independent risk factor.
Related Papers (5)